Lihuayi Weiyuan Chemical Co., Ltd. (SHA:600955)
China · Delayed Price · Currency is CNY 19.61
-0.64 (-3.16%)
At close: Feb 13, 2026
Lihuayi Weiyuan Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 9,045 | 9,507 | 7,037 | 7,790 | 9,611 | 4,351 |
Other Revenue | 15.23 | 15.23 | 13 | 8.22 | 23.59 | 35.72 |
| 9,061 | 9,522 | 7,050 | 7,798 | 9,635 | 4,386 | |
Revenue Growth (YoY) | -2.95% | 35.06% | -9.59% | -19.06% | 119.65% | 9.86% |
Cost of Revenue | 9,106 | 9,430 | 6,836 | 6,994 | 6,649 | 3,271 |
Gross Profit | -45.49 | 91.97 | 214.11 | 803.68 | 2,985 | 1,116 |
Selling, General & Admin | 123.53 | 101.31 | 111.61 | 89.98 | 76.22 | 56 |
Research & Development | 33.4 | 36.8 | 31.11 | 28.06 | 15.47 | 9.23 |
Other Operating Expenses | -30.16 | -101.43 | 12.99 | 20.4 | 53.82 | 22.19 |
Operating Expenses | 127.01 | 33.79 | 158.67 | 138.44 | 145.51 | 87.42 |
Operating Income | -172.5 | 58.17 | 55.44 | 665.24 | 2,840 | 1,028 |
Interest Expense | -72.98 | -34.77 | -8.97 | -6.38 | -21.56 | -81.3 |
Interest & Investment Income | 13.1 | 22.04 | 39.45 | 108.37 | 20.16 | 2.79 |
Currency Exchange Gain (Loss) | -0.44 | -0.44 | 0.85 | -1.35 | 0.06 | 0.05 |
Other Non Operating Income (Expenses) | -1.11 | -0.68 | -0.65 | -0.61 | -0.8 | -0.28 |
EBT Excluding Unusual Items | -233.92 | 44.32 | 86.12 | 765.28 | 2,838 | 949.54 |
Gain (Loss) on Sale of Investments | -0.21 | 0.21 | 0.13 | 2.63 | 13.77 | - |
Gain (Loss) on Sale of Assets | -13.86 | -1.15 | -0.94 | -5.49 | -1.93 | -5.71 |
Asset Writedown | -21.2 | - | - | -6.53 | -0.77 | -5.46 |
Other Unusual Items | 14.47 | 13.69 | 19.06 | 32.23 | 9.54 | 7.78 |
Pretax Income | -254.73 | 57.07 | 104.42 | 788.29 | 2,858 | 947.17 |
Income Tax Expense | -44.07 | 0.48 | 5.8 | 180.51 | 708.55 | 232.06 |
Net Income | -210.66 | 56.59 | 98.62 | 607.77 | 2,150 | 715.11 |
Net Income to Common | -210.66 | 56.59 | 98.62 | 607.77 | 2,150 | 715.11 |
Net Income Growth | - | -42.62% | -83.77% | -71.73% | 200.61% | 236.66% |
Shares Outstanding (Basic) | 562 | 566 | 548 | 548 | 455 | 413 |
Shares Outstanding (Diluted) | 562 | 566 | 548 | 548 | 455 | 413 |
Shares Change (YoY) | 2.31% | 3.29% | 0.06% | 20.22% | 10.18% | 13.05% |
EPS (Basic) | -0.38 | 0.10 | 0.18 | 1.11 | 4.72 | 1.73 |
EPS (Diluted) | -0.38 | 0.10 | 0.18 | 1.11 | 4.72 | 1.73 |
EPS Growth | - | -44.44% | -83.78% | -76.48% | 172.83% | 198.28% |
Free Cash Flow | -871.35 | -550.92 | -3,769 | -1,958 | 1,710 | 628.36 |
Free Cash Flow Per Share | -1.55 | -0.97 | -6.88 | -3.58 | 3.75 | 1.52 |
Dividend Per Share | 0.030 | 0.030 | 0.055 | 0.166 | 0.391 | - |
Dividend Growth | -45.45% | -45.45% | -66.87% | -57.55% | - | - |
Gross Margin | -0.50% | 0.97% | 3.04% | 10.31% | 30.99% | 25.44% |
Operating Margin | -1.90% | 0.61% | 0.79% | 8.53% | 29.47% | 23.44% |
Profit Margin | -2.33% | 0.59% | 1.40% | 7.79% | 22.31% | 16.30% |
Free Cash Flow Margin | -9.62% | -5.79% | -53.46% | -25.10% | 17.75% | 14.32% |
EBITDA | 806.91 | 810.22 | 504.34 | 1,078 | 3,237 | 1,377 |
EBITDA Margin | 8.91% | 8.51% | 7.15% | 13.83% | 33.59% | 31.39% |
D&A For EBITDA | 979.4 | 752.04 | 448.9 | 413.25 | 396.91 | 348.59 |
EBIT | -172.5 | 58.17 | 55.44 | 665.24 | 2,840 | 1,028 |
EBIT Margin | -1.90% | 0.61% | 0.79% | 8.53% | 29.47% | 23.44% |
Effective Tax Rate | - | 0.84% | 5.56% | 22.90% | 24.79% | 24.50% |
Revenue as Reported | 9,061 | 9,522 | 7,050 | 7,798 | 9,635 | 4,386 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.